IL15 and neoplasm: To characterize the distribution of IL-15 complexes and anti-PD-1 mAb in situ and track the interactions with immune cells within the tumor, we fluorescently labeled IL-15Rα-Fc with Cy5 and anti-PD-1 mAb with Cy3.